Skip to main content

Table 2 Cox proportional hazards model for TCGA patients

From: A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Characteristic

Hazard ratio (95% CI)

p value

CDKN2A alteration

2.7 (1.4–5.1)

0.002*

Unknown stage (reference)

1

 

Localized tumor at diagnosis

0.42 (0.23–0.79)

0.007*

Metastasis at diagnosis

1.79 (1.06–3)

0.03*

Age at diagnosis

1.03 (1.01–1.05)

0.002*

Tumor size (cm)

1 (0.99–1.01)

0.053

Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329